Siemens gets EU OK for Dade buy:
This article was originally published in Clinica
Executive Summary
German multinational Siemens is closer to clinching its third IVD buy, after its proposed acquisition of Dade Behring received European antitrust approval yesterday. The deal had cleared US regulatory hurdles in September. Siemens said it expects to complete the transaction shortly after the expiration of its cash tender offer at midnight, October 31. Siemens entered an agreement in July to buy Dade for $7bn in cash ($77 per share) - the move is in line with the Erlangen-based group's strategy to become a full-service diagnostics company (see Clinica No 1267, p 1).